How Long Does a Cough From RSV Last?

An RSV cough typically lasts one to three weeks in most otherwise healthy people, though the exact timeline depends heavily on age and overall health. In children, the acute cough usually improves within five to seven days and clears by about two weeks; in adults, the average illness stretches closer to nine or ten days. But these averages mask a wide range. For older adults, the immunocompromised, and infants who develop lower respiratory tract infections, the cough can persist for a month or longer, and in some cases RSV triggers airway changes that produce on-and-off coughing and wheezing for months.

The Typical Timeline in Children

RSV is the virus behind roughly 70 percent of bronchiolitis cases in young children. In a typical course, the illness begins looking like an ordinary cold: runny nose, mild fever, fussiness. The cough usually appears within a day or two and intensifies over the next several days. For most children, the worst of the acute symptoms, including cough, improve within five to seven days, and the cough itself resolves by about two weeks.1Kendig’s Disorders of the Respiratory Tract in Children. Bronchiolitis That two-week window is a reasonable benchmark for parents, but it applies to children whose infection stays in the upper airways or causes only mild bronchiolitis.

When the infection moves deeper into the lungs, the picture changes. Infants who develop moderate-to-severe bronchiolitis or RSV pneumonia often have a cough that lingers well beyond two weeks. Research has documented prolonged respiratory symptoms in young children, including cough, wheezing, and altered lung function, lasting weeks to months after the initial infection.2Journal of Clinical Virology. Unrecognized prolonged viral replication in the pathogenesis of human RSV infection The younger the child and the more severe the initial episode, the longer the cough tends to hang around.

How Long RSV Cough Lasts in Adults

Adults tend to think of RSV as a kids’ disease, and many never realize they have it. But when researchers have tracked RSV illness in otherwise healthy working-age adults, the average duration was about 9.5 days, which is significantly longer than the roughly 6.8 days seen with influenza in the same study group.3Clinical Infectious Diseases. Respiratory Syncytial Virus Infections in Previously Healthy Working Adults Cough was a prominent symptom throughout the illness, and some people reported it lingering a few days after other symptoms had cleared.

For healthy adults in their 20s through 50s, then, a cough lasting about a week and a half is typical. That is not terribly different from a bad cold, which is one reason RSV in adults often goes undiagnosed. The virus is circulating widely each winter; it just gets less attention than flu because it rarely puts younger adults in the hospital.

Why Older Adults Face a Longer Course

Age is the single biggest predictor of how long an RSV cough will drag on. A large primary-care study found that symptom duration was clearly associated with age for RSV but not for influenza A. Among RSV patients, the odds of still having unresolved symptoms after 28 days rose with age, and adults 75 and older were at elevated risk of their illness getting worse rather than steadily improving.4International Journal of Infectious Diseases. Respiratory syncytial virus and influenza virus infection in adult primary care patients: Association of age with prevalence, diagnostic features and illness course That finding is specific to RSV; the same study showed influenza did not follow the same age-linked pattern for lingering symptoms.

In high-risk and immunocompromised adults, symptoms frequently become lower-respiratory-tract infections rather than simple colds, and those infections can produce a cough lasting several weeks.5PubMed Central. Systematic literature review of the signs and symptoms of respiratory syncytial virus For an older adult with COPD or heart failure, the cough from RSV can blur into an exacerbation of the underlying condition, making it hard to say where the viral cough ends and the chronic cough begins. If you are caring for someone over 65 and their cough is still worsening after the first week, or has not improved at all after two weeks, that warrants medical evaluation rather than a wait-and-see approach.

Why the Cough Sticks Around After the Virus Is Gone

One of the more frustrating things about RSV is that the cough can persist long after the body has cleared the virus itself. The traditional explanation was that the immune response was simply overshooting, continuing to cause inflammation even once the pathogen was gone. That is partly true, but the picture is more specific and more interesting than generic inflammation.

RSV has a particular talent for sensitizing the sensory nerves in the airways. Just below the surface of the airway lining sits a dense network of nerve fibers. During RSV infection, the virus triggers a dramatic increase in the release of a neuropeptide called substance P, which cranks up inflammation and vascular permeability in the airways. The receptor for substance P gets significantly upregulated by RSV, and the virus also promotes a large increase in nerve growth factor and neurotrophin receptors. The result is that the sensory nerves across the respiratory tract become reorganized and hyper-reactive, both during and after the infection.6The Pediatric Infectious Disease Journal. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection In practical terms, the airways stay twitchy. Triggers that would normally be ignored, like cold air, exercise, or mild irritants, can set off a cough reflex for weeks or even months after the acute illness has passed.

This neuroimmune mechanism helps explain something that puzzles many parents and patients: why a PCR test can come back negative for RSV while the cough keeps going. The virus is gone, but the nerves it rewired are still overreacting. The cough at that point is not an ongoing infection; it is the aftermath of one.

Secondhand Smoke and Severity

Not everyone with RSV has the same starting point, and environmental factors can make the cough worse and longer-lasting. Passive smoke exposure is one of the best-documented aggravators. In children hospitalized for RSV, those who had recent secondhand smoke exposure, confirmed by measuring a tobacco metabolite in urine, had significantly lower oxygen levels on admission and higher clinical severity scores than children without smoke exposure. Nearly 28 percent of the smoke-exposed group needed supplemental oxygen on arrival, compared with just 4 percent of the unexposed group.7Pediatric Pulmonology. Increased severity of respiratory syncytial virus airway infection due to passive smoke exposure

More severe disease at the outset generally translates into a longer recovery, including a longer-lasting cough. If you have a child with RSV and there are smokers in the household, keeping the child completely away from smoke exposure is one of the few things that may shorten the tail end of their illness. The same principle applies to adults: smokers and people regularly exposed to secondhand smoke tend to have a rougher, more prolonged course with RSV.

When RSV Cough Becomes Recurrent Wheezing

For some children, the story does not end when the initial RSV cough resolves. A well-established body of evidence links severe RSV infections in infancy to recurrent wheezing episodes and asthma-like symptoms in the years that follow. A meta-analysis found that infants who had been infected with RSV were about three times as likely to develop wheezing compared to uninfected infants, and they had roughly 2.6 times the risk of wheezing illnesses even after recovery from the initial infection.8PubMed Central. Clinical manifestations of respiratory syncytial virus infection and the risk of wheezing and recurrent wheezing illness: a systematic review and meta-analysis

Whether RSV actually causes asthma or simply unmasks it in children who were already predisposed is still debated. The immunological evidence points to RSV skewing the immune response in a direction that favors airway hyper-reactivity in susceptible children, including dampening antiviral immunity and promoting the kind of immune signaling associated with allergic responses.9PubMed Central. Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions Regardless of the exact causal chain, the practical implication is real: if your child had a significant RSV infection in infancy and now gets a lingering cough with every cold, or wheezes during exercise or at night, it is worth discussing with a pediatrician rather than dismissing it as a series of unrelated colds.10Annals of Allergy, Asthma & Immunology. The impact of respiratory syncytial virus on asthma development and exacerbation

What Helps and What Does Not

There is no antiviral medication widely available that shortens an RSV cough once you already have it. Most treatment is supportive: fluids, rest, saline drops for congestion, and for young children, suctioning the nose. Honey (for children over one year) has some evidence for soothing nighttime cough in general respiratory infections and is commonly recommended, though the evidence is not RSV-specific. Over-the-counter cough suppressants are not recommended for young children and have limited evidence of benefit in adults with viral coughs.

One approach that sounds logical but has not panned out is giving inhaled corticosteroids to infants after RSV bronchiolitis in the hope of preventing the recurrent wheezing that often follows. A randomized trial tested high-dose inhaled beclometasone given during the first three months after RSV hospitalization and found no meaningful difference in days with wheeze or in the proportion of infants who went on to wheeze. About 61 percent of the treated group wheezed compared to 62 percent of the placebo group.11BMJ. The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial The takeaway is that routinely giving inhaled steroids after RSV to prevent later cough and wheeze is not supported.

For adults 60 and older, the newer RSV vaccines represent the first tool that can actually reduce the severity of symptoms. In a study of one of the prefusion F protein vaccines, vaccinated adults who still got breakthrough RSV infections had notably lower respiratory symptom severity scores than those who received placebo.12Influenza and Other Respiratory Viruses. The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age Lower severity at the outset plausibly means a shorter cough, although the trial measured peak symptom scores rather than cough duration specifically. For older adults, the protective monoclonal antibodies available for infants (like nirsevimab) serve a similar purpose on the prevention side, reducing the chance of severe disease and the prolonged cough that comes with it.

How RSV Cough Compares to Other Winter Viruses

If you are trying to figure out whether that lingering cough is RSV or something else, symptom profiles alone will not give you a definitive answer. RSV, influenza, rhinovirus, and SARS-CoV-2 all produce cough at high rates in community settings. One study found that cough was reported by about 83 percent of RSV cases, compared to 91 percent of influenza cases, 87 percent of rhinovirus cases, and 81 percent of Omicron BA.5 cases.13Scientific Reports. Symptom profiles of community cases infected by influenza, RSV, rhinovirus, seasonal coronavirus, and SARS-CoV-2 variants of concern The differences are not dramatic enough to diagnose by cough alone.

Where RSV does stand out is in its duration compared to flu. As noted earlier, the average illness length in healthy adults was about 9.5 days for RSV versus 6.8 days for influenza, making RSV roughly 40 percent longer.3Clinical Infectious Diseases. Respiratory Syncytial Virus Infections in Previously Healthy Working Adults In older adults, the gap widens further because RSV symptom duration scales with age while influenza A does not show the same pattern.4International Journal of Infectious Diseases. Respiratory syncytial virus and influenza virus infection in adult primary care patients: Association of age with prevalence, diagnostic features and illness course So if you have what feels like a cold that is taking noticeably longer to clear than usual, especially the cough component, RSV is a reasonable suspect during winter months.

When to See a Doctor About an RSV Cough

Most RSV coughs resolve on their own without medical intervention. But certain patterns warrant a visit. In infants, watch for signs of labored breathing: flaring nostrils, the skin pulling in between or below the ribs with each breath, a breathing rate that looks unusually fast, or pauses in breathing. Any of these in a baby under six months is worth an urgent evaluation. A cough that is getting worse rather than better after the first week, or one accompanied by a new fever after symptoms had been improving, can signal a secondary bacterial infection.

In adults, the red flags are similar in principle. A cough that is progressively worsening after the first week, shortness of breath at rest, or chest pain deserve medical attention. For adults over 65 or anyone with chronic lung or heart disease, the threshold for seeking care should be lower. As the evidence shows, people in that age group are disproportionately likely to experience a prolonged or deteriorating course with RSV. A week of worsening cough in a 78-year-old with COPD is a different situation than the same cough in an otherwise healthy 35-year-old, and treating them with the same wait-it-out patience can lead to missed opportunities for supportive care that prevents hospitalization.